1978
DOI: 10.1007/bf00421240
|View full text |Cite
|
Sign up to set email alerts
|

Somatotrophic diabetes: Insulin release responses to arginine and glucagon in dogs

Abstract: Growth hormone injected daily in 6 dogs for 6 days caused a 20-fold elevation in fasting serum immunoreactive insulin (IRI) without appreciable change in serum glucose in 1 day. In the somatotrophic diabetes that occurred after 2 days, the hyperinsulinaemia was maintained and the serum IRI/glucose (I/G) ratio declined from the early high level but remained elevated. During this treatment, in response to glucose infusion, the rise in serum IRI above the initially high fasting level was 16 times the normal. In r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
11
0

Year Published

1979
1979
1991
1991

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 13 publications
(12 citation statements)
references
References 30 publications
1
11
0
Order By: Relevance
“…The injection of arginine (0.4 g/kg body weight IV) in 5 dogs at about day 20 of metasomatotrophic dia- In this arginine test in normal dogs, as reported previously [12] serum IRI rapidly rose to over 4-fold and the I/G ratio rose 3-fold, with fractional rises in serum glucose and NEFA, of about 50%.…”
Section: Response To Argininesupporting
confidence: 65%
See 2 more Smart Citations
“…The injection of arginine (0.4 g/kg body weight IV) in 5 dogs at about day 20 of metasomatotrophic dia- In this arginine test in normal dogs, as reported previously [12] serum IRI rapidly rose to over 4-fold and the I/G ratio rose 3-fold, with fractional rises in serum glucose and NEFA, of about 50%.…”
Section: Response To Argininesupporting
confidence: 65%
“…In the control period of 4 months duration, the dogs became accustomed to the laboratory conditions and the testing procedures. The tests were performed as described previously [12] about 17 h after a meal and were preceded by the withdrawal of two 6 ml samples of venous blood. Glucose (1.0 g/kg body weight) was given IV within one minute, as a 50% solution (W/V) in 0.154 mol NaC1/1, after allowing ample time for equilibration of the a and b anomers.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Sensi et al [14] studied the in vitro inhibition of NEG by lysine, the main amino acid target in proteins for the initial Schiff base reaction. While the pharmacology and diagnostic use of arginine, another dibasic amino acid, for the management of diabetes patients is amply documented [15][16][17], its role as a potential inhibitor of NEG has not been investigated as yet. In contrast to lysine proteinbound arginine seems to be no target for the aldehyde to Schiff base pathway and, therefore, for NEG in vitro [18].…”
mentioning
confidence: 99%
“…This combination of growth and functional deficiency suggests the malfunction of a negative feedback for a hypothetical insulotrophic factor: a situation comparable to the TSH-induced enlargement of the thyroid following pharma cologic block of thyroid hormone biosynthesis. A prime suspect in the produc tion of this factor is the anterior pituitary, since hypopituitarism is associated with decreased B cell activity and hypoinsulinism (1,13,22,30), while pituitary hyperfunction, pituitary extracts and especially growth hormone, increase the size and granule content of the B cells in hypophysectomized animals (22,30), and stimulate the secretion of insulin (6), even though they may induce diabetes (2,25). The relationship between anterior pituitary and A cells is less clear.…”
Section: Introductionmentioning
confidence: 99%